Ireland
--:--IST
Latest
Clinical Trials in Germany / NCT07485686
Enrolling by invitation Observational

Multicentre Prospective Observational Cohort Study Aiming to Collect Medical Data, Create a Database to Facilitate Clinical and Fundamental Research Into Urinary Tract Infections With the Ultimate Goal of Improving Their Treatment.

NCT07485686 · tracked via the Priya Life Science Germany tracker
Sponsor
Angela HUTTNER
Phase
Observational
Started
2023-06-06
Last updated
2026-03-20

Condition(s) studied

Urinary Tract Infection(UTI)Urinary Tract Infection, RecurrentUTI - Urinary Tract Infection

Study summary

The goal of this prospective observational study is to collect epidemiological, clinical, microbiological, genetic, and behavioral data on individuals with UTIs. The goal is to better understand which interventions are effective and, subsequently, to facilitate studies that will improve our understanding of the condition, enhance patient care and relief, and help combat antimicrobial resistance. This project will enable us to study episodes of urinary tract infections over a period of at least 2 years and up to 5 years.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Urinary symptoms/signs suggestive of UTI (as determined by investigators), or a history of such symptoms/signs. Exclusion Criteria: * Unwillingness to provide informed consent (for patients with capacity or for the representatives of those without capacity) and/or inability to provide informed consent (for patients without capacity and without representation).

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Universitätsklinikum Frankfurt Frankfurt Germany
Leiden University Medical Center (LUMC) Leiden Netherlands
Hôpitaux Universitaires de Genève Geneva Canton of Geneva
Universitäts-Kinderspital beider Basel Basel Switzerland
Universitätsspital Zürich Zurich Switzerland
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07485686 on ClinicalTrials.gov ↗ ← All trials in Germany